473732-95-5

Usage

Uses

Used in Pharmaceutical Industry:
(S)-1-(5-METHYLFURAN-2-YL)PROPAN-1-AMINE is used as a building block in the synthesis of pharmaceuticals for its potential to contribute to the development of new drugs. Its structural features and biological activities make it a valuable component in the creation of innovative medicinal compounds.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (S)-1-(5-METHYLFURAN-2-YL)PROPAN-1-AMINE is employed as a research chemical. It aids scientists in understanding its interactions with biological targets and contributes to the advancement of drug discovery processes by providing insights into its potential therapeutic applications.

Relevant academic research and scientific papers

THIADIAZOLEDIOXIDES AND THIADIAZOLEOXIDES AS CXC- AND CC-CHEMOKINE RECEPTOR LIGANDS

Disclosed are novel compounds of the formula (IA) and the pharmaceutically acceptable salts and solvates thereof. Examples of groups comprising Substituent A include heteroaryl, aryl, heterocycloalkyl, cycloalkyl, aryl, alkynyl, alkenyl, aminoalkyl, alkyl or amino. Examples of groups comprising Substituent B include aryl and heteroaryl. Also disclosed is a method of treating a chemokine mediated diseases, such as, cancer, angiogenisis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, acute pain, acute and chronic inflammatory pain, and neuropathic pain using a compound of formula (IA).

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.

3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

There are disclosed compounds of the formula or a pharmaceutically acceptable salt or solvate thereof which are useful for the treatment of chemokine-mediated diseases such as acute and chronic inflammatory disorders and cancer.